Internal Medicine, Infectious Disease · Huntsville, AL
NPI
1992716120
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
250 Chateau Dr SW, Suite 115
Huntsville, AL, 35801
Phone (256) 533-4645
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
80,297 services
Medicare patients, 2024
476
Average age 75
Drug cost, 2024
$2.0M
2,669 prescriptions
Company payments, 2025
$2,293
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott D Parker was code J0875 (injection, dalbavancin, 5 mg), 22,900 times for 37 patients. In total Scott D Parker billed 80,297 services in 55 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0875 Injection, dalbavancin, 5 mg | Office | 22,900 | 37 | $12.13 | $278K |
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 32 | $20.22 | $68K |
| 99214 Office E&M - Established | Office | 621 | 211 | $73.47 | $46K |
| 11042 Debridement | Office | 412 | 81 | $41.93 | $17K |
| 96365 Intravenous Infusion, Hydration | Office | 394 | 78 | $41.75 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 383 | 93 | $56.69 | $22K |
| 96366 Intravenous Infusion, Hydration | Office | 233 | 39 | $14.00 | $3,261 |
| 96372 Injection Administration | Office | 170 | 45 | $10.22 | $1,737 |
| 99204 Office E&M - New | Office | 102 | 102 | $105.78 | $11K |
| 99223 Hospital E&M - Initial | Facility | 95 | 82 | $124.23 | $12K |
| 99222 Hospital E&M - Initial | Facility | 51 | 45 | $91.62 | $4,673 |
| 11045 Debridement | Office | 44 | 13 | $16.70 | $735 |
| 97597 Debridement | Office | 32 | 20 | $27.77 | $888 |
| 11043 Debridement | Office | 27 | 11 | $106.59 | $2,878 |
By year: 2022 $471K for 12,738 services; 2023 $2.5M for 90,942 services; 2024 $1.3M for 80,297 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott D Parker prescribed most often to Medicare patients was Doxycycline Hyclate, with 233 prescriptions and refills. In total Scott D Parker wrote 2,669 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 233 | 412 | 99 | $8,773 |
| Levofloxacin Generic | 221 | 236 | 101 | $2,034 |
| Dalvance Dalbavancin Hcl | 193 | 193 | 59 | $772K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 167 | 218 | 79 | $5,872 |
| Cephalexin Generic | 166 | 334 | 61 | $4,738 |
| Sodium Chloride 0.9 % Sodium Chloride | 104 | 104 | 23 | $577 |
| Ertapenem Ertapenem Sodium | 99 | 99 | 18 | $39K |
| Dextrose In Water Dextrose 5 % In Water | 85 | 85 | 31 | $347 |
| Clindamycin Hcl Generic | 84 | 142 | 38 | $2,819 |
| Rifampin Generic | 72 | 107 | 21 | $7,181 |
| Cefepime Hcl Generic | 72 | 72 | 13 | $10K |
| Fluconazole Generic | 67 | 76 | 40 | $1,243 |
| Cefpodoxime Proxetil Generic | 65 | 71 | 36 | $9,218 |
| Daptomycin Generic | 64 | 64 | 15 | $53K |
| Azithromycin Generic | 62 | 64 | 11 | $1,537 |
Brand drugs: 692 claims; generic drugs: 1,977 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott D Parker $2,293 ($2,293 in general payments such as food, travel and fees) from 21 companies. The largest payer was Insmed, Inc. with $332.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 17 | $332 |
| ViiV Healthcare Company GSK | 14 | $294 |
| CSL Behring CSL.AX | 8 | $272 |
| Astellas Pharma US Inc 4503.T | 6 | $243 |
| Abbvie Inc. ABBV | 10 | $178 |
| Cumberland Pharmaceuticals, Inc. CPIX | 21 | $160 |
| Merck Sharp & Dohme LLC MRK | 6 | $158 |
| Melinta Therapeutics, LLC | 4 | $106 |
| Theratechnologies Inc. THTX | 4 | $102 |
| MIMEDX Group, Inc. MDXG | 3 | $89.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.